Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. uri icon

authors

  • Sparks, Jeffrey A
  • Mateus, Elsa F
  • Lawson-Tovey, Saskia
  • Trupin, Laura
  • Rush, Stephanie
  • Katz, Patricia
  • Schmajuk, Gabriela
  • Jacobsohn, Lindsay
  • Wise, Leanna
  • Gilbert, Emily L
  • Duarte-García, Ali
  • Wallace, Zachary S
  • Valenzuela-Almada, Maria O
  • Pons-Estel, Guillermo J
  • Isnardi, Carolina A
  • Berbotto, Guillermo A
  • Hsu, Tiffany Y-T
  • D'Silva, Kristin M
  • Patel, Naomi J
  • Kearsley-Fleet, Lianne
  • Schäfer, Martin
  • Ribeiro, Sandra Lúcia Euzébio
  • Seet, Andrea M
  • Al Emadi, Samar
  • Tidblad, Liselotte
  • Scirè, Carlo Alberto
  • Raffeiner, Bernd
  • Thomas, Thierry
  • Flipo, René-Marc
  • Avouac, Jérôme
  • Seror, Raphaèle
  • Bernardes, Miguel
  • Cunha, Maria Margarida
  • Gianfrancesco, Milena A
  • Hasseli, Rebecca
  • Schulze-Koops, Hendrik
  • Müller-Ladner, Ulf
  • Specker, Christof
  • Souza, Viviane Angelina de
  • Mota, Licia Maria Henrique da
  • Gomides, Ana Paula Monteiro
  • Dieudé, Philippe
  • Nikiphorou, Elena
  • Kronzer, Vanessa L
  • Izadi, Zara
  • Namrata Singh, MD MSCI
  • Ugarte-Gil, Manuel F
  • Wallace, Beth
  • Akpabio, Akpabio
  • Thomas, Ranjeny
  • Bhana, Suleman
  • Costello, Wendy
  • Grainger, Rebecca
  • Hausmann, Jonathan S
  • Liew, Jean W
  • Hyrich, Kimme L
  • Sirotich, Emily
  • Sufka, Paul
  • Robinson, Philip C
  • Machado, Pedro M
  • Yazdany, Jinoos
  • Strangfeld, Anja
  • Gossec, Laure
  • Carmona, Loreto

publication date

  • January 1, 2021